LEXARIA BIOSCIENCE CORP. Sales Revenue, Goods, Net (Deprecated 2018-01-31)
LEXARIA BIOSCIENCE CORP. (LEXX) reported Sales Revenue, Goods, Net (Deprecated 2018-01-31) of $14.19 thousand for the 9-month period ending 2018-05-31, per its 10-Q filed 2018-07-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueGoodsNet · last filed 2018-07-13
- LEXARIA BIOSCIENCE CORP. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2018-05-31 was $2.48K, a 74.99% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2018-02-28 was $3.70K, a 71.74% increase year-over-year.
- LEXARIA BIOSCIENCE CORP. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-11-30 was $8.01K, a 826.85% increase year-over-year.
- LEXARIA BIOSCIENCE CORP. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-08-31 was $50.71K, a 492.23% increase year-over-year.
- LEXARIA BIOSCIENCE CORP. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2017 was $63.64K, a 56.29% increase from fiscal 2016.
- LEXARIA BIOSCIENCE CORP. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2016 was $40.72K, a 176.96% increase from fiscal 2015.
- LEXARIA BIOSCIENCE CORP. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2015 was $14.70K.
- LEXARIA BIOSCIENCE CORP. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2014 was $0.00.
| Period end | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|---|
| 2018-05-31 | $2.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-07-13 | $6.18K derived: sum of 2 quarters · filed 2018-07-13 | $14.19K 10-Q · filed 2018-07-13 | $64.89K derived: sum of 4 quarters · filed 2018-07-13 | |
| 2018-02-28 | $3.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-04-12 | $11.71K 10-Q · filed 2018-04-12 | $62.42K derived: sum of 3 quarters · filed 2018-04-12 | $72.33K derived: sum of 4 quarters · filed 2018-07-13 | |
| 2017-11-30 | $8.01K 10-Q · filed 2018-01-12 | $58.72K derived: sum of 2 quarters · filed 2018-01-12 | $68.63K derived: sum of 3 quarters · filed 2018-07-13 | $70.78K derived: sum of 4 quarters · filed 2018-07-13 | |
| 2017-08-31 | $50.71K derived: 10-K 12 month − 10-Q 9 month · filed 2017-11-27 | $60.62K derived: sum of 2 quarters · filed 2018-07-13 | $62.77K derived: sum of 3 quarters · filed 2018-07-13 | $63.64K 10-K · filed 2017-11-27 | |
| 2017-05-31 | $9.91K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-07-13 | $12.07K derived: sum of 2 quarters · filed 2018-07-13 | $12.93K 10-Q · filed 2018-07-13 | $21.49K derived: sum of 4 quarters · filed 2018-07-13 | |
| 2017-02-28 | $2.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-04-12 | $3.02K 10-Q · filed 2018-04-12 | $11.58K derived: sum of 3 quarters · filed 2018-04-12 | $17.80K derived: sum of 4 quarters · filed 2018-04-12 | |
| 2016-11-30 | $864.00 10-Q · filed 2018-01-12 | $9.22K 10-Q · filed 2017-01-13 | $9.43K derived: sum of 2 quarters · filed 2018-01-12 | $15.64K derived: sum of 3 quarters · filed 2018-01-12 | $30.80K derived: sum of 4 quarters · filed 2018-01-12 |
| 2016-08-31 | $8.56K derived: 10-K 12 month − 10-Q 9 month · filed 2017-11-27 | $14.78K derived: sum of 2 quarters · filed 2017-11-27 | $29.93K derived: sum of 3 quarters · filed 2017-11-27 | $40.72K 10-K · filed 2017-11-27 | |
| 2016-05-31 | $6.21K 10-Q · filed 2016-07-13 | $21.37K derived: sum of 2 quarters · filed 2016-07-13 | $32.16K 10-Q · filed 2016-07-13 | $36.79K derived: sum of 4 quarters · filed 2017-01-13 | |
| 2016-02-29 | $15.15K 10-Q · filed 2016-04-13 | $25.94K 10-Q · filed 2016-04-13 | $30.57K derived: sum of 3 quarters · filed 2017-01-13 | $37.76K derived: sum of 4 quarters · filed 2017-01-13 | |
| 2015-11-30 | $10.79K 10-Q · filed 2017-01-13 | $15.42K derived: sum of 2 quarters · filed 2017-01-13 | $22.61K derived: sum of 3 quarters · filed 2017-01-13 | $25.49K derived: sum of 4 quarters · filed 2017-01-13 | |
| 2015-08-31 | $4.63K derived: 10-K 12 month − 10-Q 9 month · filed 2016-11-29 | $11.82K derived: sum of 2 quarters · filed 2016-11-29 | $14.70K derived: sum of 3 quarters · filed 2016-11-29 | $14.70K 10-K · filed 2016-11-29 | |
| 2015-05-31 | $7.19K 10-Q · filed 2016-07-13 | $10.07K derived: sum of 2 quarters · filed 2016-07-13 | $10.07K 10-Q · filed 2016-07-13 | $10.07K derived: sum of 4 quarters · filed 2016-07-13 | |
| 2015-02-28 | $2.88K 10-Q · filed 2016-04-13 | $2.88K 10-Q · filed 2016-04-13 | $2.88K derived: sum of 3 quarters · filed 2016-04-13 | $2.88K derived: sum of 4 quarters · filed 2016-04-13 | |
| 2014-11-30 | $0.00 10-Q · filed 2016-01-08 | $0.00 derived: sum of 2 quarters · filed 2016-01-08 | $0.00 derived: sum of 3 quarters · filed 2016-01-08 | $0.00 derived: sum of 4 quarters · filed 2016-01-08 | |
| 2014-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-11-27 | $0.00 derived: sum of 2 quarters · filed 2015-11-27 | $0.00 derived: sum of 3 quarters · filed 2015-11-27 | $0.00 10-K · filed 2015-11-27 | |
| 2014-05-31 | $0.00 10-Q · filed 2015-07-14 | $0.00 derived: sum of 2 quarters · filed 2015-07-14 | $0.00 10-Q · filed 2015-07-14 | ||
| 2014-02-28 | $0.00 10-Q · filed 2015-04-14 | $0.00 10-Q · filed 2015-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |